A5033917264- Tryptophan and brain disorders
- Higher Education and Employability
- Healthcare Systems and Reforms
- Chronic Lymphocytic Leukemia Research
- COVID-19 and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Pulmonary Hypertension Research and Treatments
- Lymphoma Diagnosis and Treatment
- Chronic Disease Management Strategies
- Healthcare Systems and Public Health
- Musculoskeletal pain and rehabilitation
- Entrepreneurship Studies and Influences
- Advanced Breast Cancer Therapies
- Heart Failure Treatment and Management
- Mindfulness and Compassion Interventions
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Perfectionism, Procrastination, Anxiety Studies
- Medical Education and Admissions
- Viral Infections and Immunology Research
- Liver Disease and Transplantation
- Indian Economic and Social Development
- Natural Antidiabetic Agents Studies
- Cardiovascular Health and Risk Factors
- Psychological Well-being and Life Satisfaction
- Vitamin D Research Studies
IQ Solutions
2025
IQVIA (United States)
2023-2025
Reading Hospital
2025
Institute of Transplantation Sciences
2025
West Virginia University
2019-2023
University of North Texas
2021
University of North Texas Health Science Center
2021
Sinhgad Dental College and Hospital
2013
To evaluate the overall satisfaction, device usability, and injection experience of MS patients self-administering ofatumumab using Sensoready® autoinjector in United States (US). This US-based, cross-sectional survey study included with (≥ 18 years) who self-administered Sensoready within previous 12 months survey. Eligible were administered a 30-item de novo questionnaire that focused on convenience/flexibility for travel device, user confidence, experience, time to administer injection....
Background: Hypertension (HTN)-induced stroke is a leading cause of mortality among older adults in the United States. Analyzing trends and disparities HTN-associated essential for guiding targeted interventions informing policy decisions. Objectives: This study aims to evaluate aged ≥65 years, with focus on demographic geographic variations, using comprehensive nationwide death certificate data. Methods: We analyzed data from CDC WONDER database spanning 1999 2020 assess HTN-related...
BACKGROUND: MAFLD is characterized by hepatic fat accumulation and strongly associated with obesity, insulin resistance, dyslipidemia It known as manifestation of metabolic syndrome which can progress to fibrosis, cirrhosis, carcinoma. We report a case 47 years old male MAFLD, referred the physiotherapy department for exercise intervention. On evaluation, we found central/abdominal dyslipidemia, diabetes-mellitus, abnormal liver function tests-(SGPT/SGOT), liver-elastography/fibro-scan...
This study examined prescription NSAIDs as one of the leading predictors incident depression and assessed direction association among older cancer survivors with osteoarthritis.This used a retrospective cohort (N = 14, 992) adults (breast, prostate, colorectal cancers, or non-Hodgkin's lymphoma) osteoarthritis. We longitudinal data from linked Surveillance, Epidemiology, End Results -Medicare for period 2006 through 2016, 12-month baseline follow-up period. Cumulative days was during An...
To identify factors and entrepreneurial characteristics associated with intrapreneurial intentions among Doctor of Pharmacy (PharmD) students in Iran.
Objective. To develop a questionnaire for measuring entrepreneurial and intrapreneurial intentions among student pharmacists to identify characteristics personality traits that are associated with these intentions. Methods. A 105-item survey instrument was developed administered all Doctor of Pharmacy (PharmD) students (incoming third year) at large public university. It consisted nine scales pertaining entrepreneurism including previously validated some newly adapted use pharmacists. Data...
During the COVID-19 pandemic, an increase in poor mental health among Asian Indians was observed United States. However, leading predictors of during pandemic remained unknown. A cross-sectional online survey administered to self-identified aged 18 and older (N = 289). Survey collected information on demographic socio-economic characteristics burden. Two novel machine learning techniques-eXtreme Gradient Boosting Shapley Additive exPlanations (SHAP) were used identify explain their...
In the United States, COVID-19 pandemic has caused increased mental health symptoms and illness. Specific subgroups such as Asian Indians in US have also been subject to additional stressors due unprecedented loss of lives their home country hate misperception that Asians are be blamed for spread SARS-CoV-2.We examined various factors including discrimination associated with COVID-19-related among Indians.We administered an online survey between May 2021 July using convenient snowball...
With the emerging opportunities for pharmacists to gain provider status, need understanding interest become a pharmacist has never been greater.To determine which entrepreneurial traits (locus of control, innovativeness, autonomy, risk-taking propensity, proactiveness, achievement motivation, people liking, problem-solving, and leadership) are associated with in becoming provider.A cross-sectional survey was conducted among second- third-year student pharmacists. Exploratory factor analysis...
To estimate the incremental absenteeism-related wage loss associated with multimorbidity and examine influence of paid sick leave policy (PSLP) on multimorbidity-associated absenteeism loss.We used Medical Expenditure Panel Survey (MEPS) 2015 data. Two-part generalized linear models (GLM) were employed, using binomial distribution gamma a log link.Nationally, was $9 billion annually among working adults. Absenteeism-related higher those than without multimorbidity. The annual lower in...
Background: Venetoclax (V) is an approved fixed-duration treatment for chronic lymphocytic leukemia and small lymphoma (CLL/SLL), either as a 12-cycle regimen (~12 months) in combination with obinutuzumab (O) the first-line (1L) setting or 24-cycle (~24 rituximab (R) relapsed/refractory (R/R) setting. Aims: To analyze real-world patterns of V+O 1L V+R R/R settings patients CLL/SLL United States. Methods: A retrospective cohort analysis was conducted using IQVIA PharMetrics® Plus database to...
<b>Background:</b> While multiple studies characterize healthcare resource utilization (HCRU) and costs of pulmonary arterial hypertension (PAH) overall, HCRU specific to end-of-life (EOL) is not well described. <b>Aim:</b> To explore EOL-related among patients with PAH. <b>Methods:</b> This retrospective cohort study analyzed data adult PAH from the IQVIA PharMetrics® Plus (P+) database (OCT2014-MAR2022). P+ does include mortality data; therefore, evidence fatality was determined by both a...
Once-monthly paliperidone palmitate (PP1M) is a long-acting injectable antipsychotic approved for the treatment of schizophrenia and schizoaffective disorder (SCA) in adults.
This retrospective study was conducted to evaluate all-cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) explore end-of-life (EOL)-related HCRU costs. Data from the IQVIA PharMetrics® Plus database (October 2014 May 2020) were analyzed identify adults (≥18 years) PAH (PAH cohort) those without PH (non-PH cohort). Patients required have data for ≥12 months before (baseline) ≥6 after (follow-up) first...
e18792 Background: In August 2019, pexidartinib became the first and only systemic therapy approved in US for treatment of symptomatic TGCT associated with severe morbidity or functional limitations not amenable to improvement surgery. As is a rare condition, real-world utilization data are limited greatly needed inform clinical use. Methods: Adults (≥18 years) ≥1 claim from 8/2/2019 - 1/1/2022 identified IQVIA Longitudinal Prescription Claims (LRx) linked Medical (Dx) databases were...
Objective: To evaluate treatment patterns, healthcare resource utilization (HRU) and costs among peripheral T-cell lymphoma (PTCL) patients in the USA. Methods: A retrospective cohort study, using IQVIA PharMetrics® Plus claims database from 1 April 2011 to 30 November 2021, identified PTCL receiving systemic treatments. Three mutually exclusive subcohorts were created based on line of therapy (LOT): 1LOT, 2LOT ≥3LOT. Common regimens, median time treatment, all-cause PTCL-related HRU...